Publications

Authors:

Dalbeni, Andrea; Ciccarese, Chiara; Bevilacqua, Michele; Benati, Marco; Caimmi, Cristian; Cerrito, Luca; Famà, Federico; Iacovelli, Roberto; Mantovani, Anna; Massari, Francesco; Meneguzzi, Alessandra; Minuz, Pietro; Montagnana, Martina; Orsolini, Giovanni; Rossini, Maurizio; Tortora, Giampaolo; Viapiana, Ombretta; Fava, Cristiano

Title:

Effects of antiangiogenetic drugs on microcirculation and macrocirculation in patients with advanced-stage renal cancer

Year:

2019

Type of item:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Language:

Inglese

Format:

Elettronico

Referee:

Sì

Name of journal:

CANCERS

ISSN of journal:

2072-6694

N° Volume:

11

Number or Folder:

1

Page numbers:

30-30

Keyword:

TKI; angiogenesis; VEGF; renal cancer; NO (Nitric Oxide); endothelin-1; capillaroscopy; hypertension

Short description of contents:

Adverse cardiovascular effects, including hypertension, were described in patients with different cancers treated with tyrosine kinase inhibitors (TKI). The mechanism of TKI-related hypertension is still debated. The aim of this work was to study the effects of TKI on blood pressure (BP), searching for a relationship with possible causative factors in patients with metastatic renal cell carcinoma. We included 29 patients in a prospective, observational study; 22 were treated with a first-line drug (sunitinib), while seven participated in the second-line treatment (axitinib or cabozantinib). Patients were investigated at the beginning of antiangiogenic therapy (T0) and at one (T1), three (T2), and six months (T3) after treatment. Patients were evaluated by office blood pressure (BP) and ultrasonography to measure flow-mediated dilatation (FMD), and carotid artery distensibility (cDC) by echocardiography and nailfold capillaroscopy. Plasma endothelin-1 (p-ET-1), urine nitrates, and proteins were also measured. At T1, systolic BP, along with U proteins and p-ET-1, increased significantly. In patients with a clinically significant increase in BP (defined as either the need for an antihypertensive drug or systolic blood pressure (SBP) T1⁻T0 ≥10 and/or SBP ≥140 mmHg and/or diastolic blood pressure (DBP) T1⁻T0 ≥5 and/or DBP ≥90 mmHg), the urine nitrate concentration was lower at T0, whereas there were no differences in the p-ET-1 and U proteins. Seventeen participants showed changes in the capillaroscopic pattern at T1 with no association with BP increases. There were no differences in the FMD, cDC, and echocardiographic parameters. Our findings are consistent with those of previous studies about BP increases by TKI, and suggest a role of nitric oxide in BP maintenance in this population.

Web page:

https://doi.org/10.3390/cancers11010030

Product ID:

105862

Handle IRIS:

11562/989460

Last Modified:

February 23, 2023

Bibliographic citation:

Dalbeni, Andrea; Ciccarese, Chiara; Bevilacqua, Michele; Benati, Marco; Caimmi, Cristian; Cerrito, Luca; Famà, Federico; Iacovelli, Roberto; Mantovani, Anna; Massari, Francesco; Meneguzzi, Alessandra; Minuz, Pietro; Montagnana, Martina; Orsolini, Giovanni; Rossini, Maurizio; Tortora, Giampaolo; Viapiana, Ombretta; Fava, Cristiano, Effects of antiangiogenetic drugs on microcirculation and macrocirculation in patients with advanced-stage renal cancer «CANCERS» , vol. 11 , n. 1 , 2019 , pp. 30-30

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo